?

Therapeutic window**: Is there a safe level of MARK inhibition?

active
open question Created: 2026-04-26T03:29:33 By: backfill_open_questions Quality: 50% ✓ SciDEX ID: open_question-3ea623a1-ab86-451a-9ddc-ba
Open Question open Wiki: mechanisms-mark-tau-phosphorylation-pathway
Therapeutic window**: Is there a safe level of MARK inhibition?
Importance Elo
1500
Field Rank
Rank #1145 in mechanisms
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page mechanisms-mark-tau-phosphorylation-pathway
Evidence Bearing On This Question
Real-world safety study of Lecanemab in Japanese AD patients
partial answer for · experiment · 55%
Tau Propagation Causality Test — Does Tau Spread Drive Neurodegeneration or Is It a Bystander?
partial answer for · experiment · 48%
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Trials Have Not Succeeded
partial answer for · experiment · 45%
Experiment Proposal (Crux): What is the evidence that blood-brain barrier (BBB) permeability changes serve as early biomarkers f [60426-210049]
discriminating experiment · experiment_proposal · 42%
HSP90-Tau Disaggregation Complex Enhancement
bears on question · hypothesis · 40%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
Experiment Proposal (Crux): What is the evidence that blood-brain barrier (BBB) permeability changes serve as early biomarkers f [60426-210049]
experiment_proposal | discriminating_experiment
HSP90-Tau Disaggregation Complex Enhancement
hypothesis | bears_on_question
Related Entities
mechanisms
Metadata
statusopen
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:33.008087'}
field_tagmechanisms
source_idmechanisms-mark-tau-phosphorylation-pathway
sub_fieldmark-tau-phosphorylation-pathway
source_kindwiki
question_hash1845f9adfeea14789e56ad30bd7183b5bdbdf95e0eb2ce59a5771c05b16479d2
question_textTherapeutic window**: Is there a safe level of MARK inhibition?
importance_elo1500
evidence_summaryExtracted from wiki page mechanisms-mark-tau-phosphorylation-pathway
evidence_xref_at2026-04-27T13:52:10.049390+00:00
tractability_score0.5
potential_impact_score0.5
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
6
0 supporting 0 contradicting 0 neutral
View full evidence profile →